drugset / Trial / NCT00620048

Stem Cell Study for Subjects With Congestive Heart Failure

NCT00620048 ↗

Phase 1 Terminated 4 enrolled Losordo, Douglas, M.D.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.

Timeline

Start
2008-03
Primary completion
2011-01
Completion
—

Outcome

Outcome not reported

Stopped (Business): “Study terminated due to lack of funding.”

Drugs

EvaluationDrugModalityDoseRoute
Subject CD34-positive cells Cell therapy — Other